Arthur Brodsky, PhD, joined Alliance for Cancer Gene Therapy in May 2026 as director of scientific content and communications, bringing experience as both a cancer researcher and science communicator covering the cutting-edge of cancer research. 

Prior to joining ACGT, Dr. Brodsky spread awareness of advances in cancer immunotherapy and immunology at the Cancer Research Institute (CRI) and the American Association for Cancer Research (AACR), including the incredible trajectory of cell therapy breakthroughs over the last decade.

In addition to highlighting the impact of cancer research, Arthur enjoys capturing and documenting the beauty of the natural world, and contributing to conservation efforts.